McCoy John A. Jr.'s Form 4 filing
Abbott Laboratories (ABT) · filed Sep 4, 2024
- Accession no.
- 0001415889-24-022826
- Filed
- Sep 4, 2024
- Trade date
- Sep 1-4, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.10K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McCoy John A. Jr.CIK 0001644207 | Officer (VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2024 | Common shares without par value | FTax withholdingDisposed | −52 | $113.27 | −$5,890.04 | 18,708 | Direct | |
| Sep 4, 2024 | Common shares without par value | SSaleDisposed | −27 | $114.83 | −$3,100.41 | 18,681 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.